HCWB
HCW Biologics Inc.
There isn't enough reported data to score HCWB yet.
HCWB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
HCWB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HCWB PE Valuation
HCWB has no meaningful PE right now: it lost money over the past year.
HCWB Forward outlook
There aren't enough analyst estimates for HCWB to show an outlook.
HCWB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$148.80 | +$33.60 |
| Q4 2024 | -$184.80 | -$16.80 |
| Q3 2024 | -$240.00 | -$108.00 |
| Q2 2024 | -$249.60 | -$124.80 |
| Q1 2024 | -$182.40 | -$62.40 |
| Q4 2023 | -$168.00 | -$67.20 |
HCWB lost $148.80 per share over the past year, a smaller loss than the year before.
HCWB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $121.7K | +1758% |
| Q1 2026 | $6.5M | +128232% |
| Q4 2025 | $27K | -93% |
| Q3 2025 | $15.6K | -96% |
| Q2 2025 | $6.6K | -99% |
| Q1 2025 | $5.1K | -100% |
| Q4 2024 | $394.8K | -70% |
| Q3 2024 | $426.4K | -50% |
HCWB's revenue is growing: $121,730 last quarter, up 1758% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2601% | +50286 points |
| Q1 2026 | 50% | +38861 points |
| Q4 2025 | -16519% | -15719 points |
| Q3 2025 | -21095% | -20230 points |
| Q2 2025 | -52887% | -50441 points |
| Q1 2025 | -38811% | -38146 points |
| Q4 2024 | -800% | +13 points |
| Q3 2024 | -865% | -270 points |
HCWB's operating margin was −2601% last quarter, up 50286 points from the same quarter a year ago.
HCWB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4M | -$683.8K |
| Q1 2026 | -$1.6M | +$1.9M |
| Q4 2025 | -$3.4M | -$407.2K |
| Q3 2025 | -$3.2M | -$276.4K |
| Q2 2025 | -$3.3M | +$1.6M |
| Q1 2025 | -$3.5M | +$219.7K |
| Q4 2024 | -$2.9M | +$4.7M |
| Q3 2024 | -$3M | +$3.3M |
HCWB has burned cash in almost every quarter: −$12M over the past year, against −$13M the year before.
HCWB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +280% | +978K shares |
| 1 year | +613% | +1.1M shares |
| 3 years | +788% | +1.2M shares |
| 5 years | +1014% | +1.2M shares |
HCWB has 1M diluted shares, up 613% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HCWB Net Leverage
HCWB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HCWB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 0.6 | Oversold |
HCWB's weekly RSI is 37 (neutral) and its Stochastic is 1 (oversold).
HCWB PE vs Healthcare Sector
HCWB has no meaningful PE right now: it lost money over the past year.
HCWB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 39% below |
| 20 week MA | $2.39 | 67% below |
| 50 week MA | $4.72 | 83% below |
| 100 week MA | $26.6 | 97% below |
| 200 week MA | $171.4 | 100% below |
HCWB is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HCWB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $1,245.6 | $600.0 | -52% |
| 2022 | $600.0 | $472.8 | -21% |
| 2023 | $472.8 | $295.2 | -38% |
| 2024 | $295.2 | $100.8 | -66% |
| 2025 | $100.8 | $8.52 | -92% |
| 2026 YTD | $8.52 | $0.80 | -91% |
HCWB has finished every year since 2021 lower, and it's down 91% so far in 2026.